Rutgers professor Elizabeth Torres hopes to take her innovative, computer-based approach towards autism and child development to a new level through a partnership with a social-emotional learning (SEL) platform provider.
As a key player in developing and transforming innovators into entrepreneurs that improve people’s lives, Rutgers, The State University of New Jersey will expand its entrepreneurship training programming and further equip faculty and student researchers with the skills and strategy needed to transition their discoveries into technologies and products, as a partner in the newly created NSF I-Corps™ Hub: Northeast Region.
Leading experts at Rutgers and Tel Aviv Universities hosted a symposium centered on the coronavirus pandemic and the research, response and lessons learned through the COVID-19 outbreak in the sister states of New Jersey and Israel.
A novel base editing technology invented at Rutgers, with the potential to be used for the creation of new cell and gene therapies, will be made available to researchers worldwide through an exclusive partnership with the Horizon Discovery Group.
Rutgers University signs two agreements with Santhera Pharmaceuticals to advance pioneering research for the treatment of congenital muscular dystrophy. The agreements complement ongoing research of Peter Yurchenco, professor at Rutgers Robert Wood Johnson Medical School and a pioneer in a novel gene therapy approach for the treatment of LAMA2-deficient congenital muscular dystrophy.
While many have been terrified by an invisible enemy, a group of drivers have known for sure that they are transporting and carrying the deadly coronavirus to the hands of Rutgers healthcare heroes with plastic face shields and white gowns.
Rutgers University and professional services company Accenture join efforts to solve the necessity of face shields and other personal protection equipment for healthcare workers and researchers on the front lines of the COVID-19 pandemic.